"Diabetes is a big deal in kidney disease. It’s the leading cause of both chronic kidney disease and end-stage kidney disease that requires transplantation, dialytic therapy, or intensive conservative care."

That’s Dr. Graham Abra, a Clinical Assistant Professor at Stanford University and Senior Director of Medical Clinical Affairs at Satellite Healthcare. Dr. Abra is joined by colleague Paul Bennett, PhD, Director of Medical Clinical Affairs at Satellite Healthcare.

Christopher Springmann: Before we get into the posters and the oral portions that you’re presenting at the ASN or American Society of Nephrology meeting, can you give us a linkage between diabetes and dialysis?

GA: It’s the leading cause of both chronic kidney disease and end-stage kidney disease that requires transplantation, dialytic therapy, or intensive conservative care. It’s a major issue that nephrologists and other professionals who work with patients with kidney disease deal with.